No association of two common SNPs at position -1727 A/T, -50 C/T of GSK-3 beta polymorphisms with schizophrenia and bipolar disorder of Korean population - PubMed (original) (raw)

. 2006 Mar 6;395(2):175-8.

doi: 10.1016/j.neulet.2005.10.059. Epub 2005 Nov 14.

Affiliations

• PMID: 16289845
• DOI: 10.1016/j.neulet.2005.10.059

No association of two common SNPs at position -1727 A/T, -50 C/T of GSK-3 beta polymorphisms with schizophrenia and bipolar disorder of Korean population

Kyu Young Lee et al. Neurosci Lett. 2006.

Abstract

Recent studies have suggested the involvement of Glycogen synthase kinase-3 beta (GSK-3 beta) in pathogenesis and treatment target of schizophrenia and bipolar disorder, which led to consider GSK-3 beta as one of the candidate genes for those disorders. However, the association analysis between GSK-3 beta and either schizophrenia or bipolar disorder is yet to be reported in Korean population. Along with 350 healthy individuals, a sample of 138 schizophrenia and 120 bipolar patients was analyzed for two common SNPs at position -1727 A/T and -50 C/T polymorphism localized in intron 1 of the gene. The results showed that allele, genotype and haplotype distributions for the two SNPs do not differ between the controls and neither schizophrenia nor bipolar disorder patients. We also analyzed the association between the controls and the combined samples of schizophrenia and bipolar disorder, but no association was found. In conclusion, these results suggest that the GSK-3 beta is not associated with the development of schizophrenia and bipolar disorder in Korean population.

PubMed Disclaimer

Similar articles

• Association between glycogen synthase kinase-3β gene polymorphisms and attention deficit hyperactivity disorder in Korean children: a preliminary study.
  Shim SH, Hwangbo Y, Kwon YJ, Lee HY, Kim JH, Yoon HK, Hwang JA, Kim YK. Shim SH, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2012 Oct 1;39(1):57-61. doi: 10.1016/j.pnpbp.2012.05.008. Epub 2012 May 31. Prog Neuropsychopharmacol Biol Psychiatry. 2012. PMID: 22658982
• Association analysis of the GSK-3beta T-50C gene polymorphism with schizophrenia and bipolar disorder.
  Szczepankiewicz A, Skibinska M, Hauser J, Slopien A, Leszczynska-Rodziewicz A, Kapelski P, Dmitrzak-Weglarz M, Czerski PM, Rybakowski JK. Szczepankiewicz A, et al. Neuropsychobiology. 2006;53(1):51-6. doi: 10.1159/000090704. Epub 2006 Jan 4. Neuropsychobiology. 2006. PMID: 16397405
• GSK-3β polymorphism discriminates bipolar disorder and schizophrenia: a systematic meta-analysis.
  Tang H, Shen N, Jin H, Liu D, Miao X, Zhu LQ. Tang H, et al. Mol Neurobiol. 2013 Dec;48(3):404-11. doi: 10.1007/s12035-013-8414-x. Epub 2013 Feb 27. Mol Neurobiol. 2013. PMID: 23440732
• A specific group of patients with diagnostic conversion from depression to bipolar disorder and finally to dementia as a mental GSK-3 disease: A hypothesis.
  Terao T, Ishii N, Hirakawa H. Terao T, et al. Bipolar Disord. 2020 Jun;22(4):356-359. doi: 10.1111/bdi.12875. Epub 2020 Jan 5. Bipolar Disord. 2020. PMID: 31742842 Review.
• Association of Single Nucleotide Polymorphisms of Cytokine Genes with Depression, Schizophrenia and Bipolar Disorder.
  Mikhalitskaya EV, Vyalova NM, Ermakov EA, Levchuk LA, Simutkin GG, Bokhan NA, Ivanova SA. Mikhalitskaya EV, et al. Genes (Basel). 2023 Jul 17;14(7):1460. doi: 10.3390/genes14071460. Genes (Basel). 2023. PMID: 37510364 Free PMC article. Review.

Cited by

• Meta-analysis of genetic association studies on bipolar disorder.
  Seifuddin F, Mahon PB, Judy J, Pirooznia M, Jancic D, Taylor J, Goes FS, Potash JB, Zandi PP. Seifuddin F, et al. Am J Med Genet B Neuropsychiatr Genet. 2012 Jul;159B(5):508-18. doi: 10.1002/ajmg.b.32057. Epub 2012 May 9. Am J Med Genet B Neuropsychiatr Genet. 2012. PMID: 22573399 Free PMC article.
• Clock genes may influence bipolar disorder susceptibility and dysfunctional circadian rhythm.
  Shi J, Wittke-Thompson JK, Badner JA, Hattori E, Potash JB, Willour VL, McMahon FJ, Gershon ES, Liu C. Shi J, et al. Am J Med Genet B Neuropsychiatr Genet. 2008 Oct 5;147B(7):1047-55. doi: 10.1002/ajmg.b.30714. Am J Med Genet B Neuropsychiatr Genet. 2008. PMID: 18228528 Free PMC article.
• Neurodevelopment in schizophrenia: the role of the wnt pathways.
  Panaccione I, Napoletano F, Forte AM, Kotzalidis GD, Del Casale A, Rapinesi C, Brugnoli C, Serata D, Caccia F, Cuomo I, Ambrosi E, Simonetti A, Savoja V, De Chiara L, Danese E, Manfredi G, Janiri D, Motolese M, Nicoletti F, Girardi P, Sani G. Panaccione I, et al. Curr Neuropharmacol. 2013 Sep;11(5):535-58. doi: 10.2174/1570159X113119990037. Curr Neuropharmacol. 2013. PMID: 24403877 Free PMC article.
• An Association Study Between Genetic Polymorphisms in Functional Regions of Five Genes and the Risk of Schizophrenia.
  Yan P, Qiao X, Wu H, Yin F, Zhang J, Ji Y, Wei S, Lai J. Yan P, et al. J Mol Neurosci. 2016 Jul;59(3):366-75. doi: 10.1007/s12031-016-0751-6. Epub 2016 Apr 7. J Mol Neurosci. 2016. PMID: 27055860
• Molecular actions and clinical pharmacogenetics of lithium therapy.
  Can A, Schulze TG, Gould TD. Can A, et al. Pharmacol Biochem Behav. 2014 Aug;123:3-16. doi: 10.1016/j.pbb.2014.02.004. Epub 2014 Feb 15. Pharmacol Biochem Behav. 2014. PMID: 24534415 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Consumer Health Information
  • MedlinePlus Health Information